Bibby, JA et al
Today, it remains legal with a prescription and can be compounded under Section 503A of the Food, Drug, and Cosmetic Act
Evidence needs to be preserved, witnesses need to be interviewed, and there are strict time limits for filing legal action
See our guide on combining peptides for more stacking guidance
10.1182/blood-2015-09-618538 Blood Summary Keywords sickle cell disease, anti-sickling agents, gene editing, gene therapy, hemoglobinopathies Citation Salinas Cisneros G and Thein SL (2020) Recent Advances in the Treatment of Sickle Cell Disease
AOD-9604 5 mg Key Specifications Peptide Name: AOD-9604 Peptide Type: Synthetic peptide fragment Derived From: C-terminal region of human growth hormone Quantity: 5mg per vial Form: Lyophilized (freeze-dried) powder Grade: Research grade Packaging: Sterile, sealed vial Common Research Applications AOD-9604 is utilized in non-clinical laboratory research related to: Metabolic pathway modeling Growth hormonerelated signaling research Peptide-receptor interaction studies Molecular stability and degradation analysis Experimental peptide behavior in controlled systems All research use must comply with institutional protocols and applicable regulations